OVID EPS Estimates
Ovid Therapeutics Inc.
$2.19
$0.00(0.00%)
42
Overall
60
Value
27
Tech
39
Quality
Market Cap
$427.70M
Volume
1.64M
52W Range
$1.18 - $3.11
Target Price
$5.74
OVID EPS estimates: the consensus estimate for Ovid Therapeutics Inc.'s current fiscal year is -$0.37 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
OVID EPS Estimates
- EPS estimate, current quarter
- $-0.08
- EPS estimate, next quarter
- $-0.09
- EPS estimate, current year
- $-0.37
- EPS estimate, next year
- $-0.38
- EPS growth, 3-year
- +33.15%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.23 |
| 2024 | $-0.37 |
| 2023 | $-0.74 |
| 2022 | $-0.77 |
| 2021 | $1.78 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $2.19 | 0% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |